110 related articles for article (PubMed ID: 12381362)
21. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.
Thomassen EA; van Veen HA; van Berkel PH; Nuijens JH; Abrahams JP
Transgenic Res; 2005 Aug; 14(4):397-405. PubMed ID: 16201406
[TBL] [Abstract][Full Text] [Related]
22. Isolation and characterization of rhesus monkey milk lactoferrin.
Davidson LA; Lönnerdal B
Pediatr Res; 1986 Feb; 20(2):197-201. PubMed ID: 3080731
[TBL] [Abstract][Full Text] [Related]
23. Separation and characterization of the C-terminal half molecule of bovine lactoferrin.
Shimazaki K; Tanaka T; Kon H; Oota K; Kawaguchi A; Maki Y; Sato T
J Dairy Sci; 1993 Apr; 76(4):946-55. PubMed ID: 8486845
[TBL] [Abstract][Full Text] [Related]
24. EndoE from Enterococcus faecalis hydrolyzes the glycans of the biofilm inhibiting protein lactoferrin and mediates growth.
Garbe J; Sjögren J; Cosgrave EF; Struwe WB; Bober M; Olin AI; Rudd PM; Collin M
PLoS One; 2014; 9(3):e91035. PubMed ID: 24608122
[TBL] [Abstract][Full Text] [Related]
25. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.
Velliyagounder K; Kaplan JB; Furgang D; Legarda D; Diamond G; Parkin RE; Fine DH
Infect Immun; 2003 Nov; 71(11):6141-7. PubMed ID: 14573629
[TBL] [Abstract][Full Text] [Related]
26. Expression of active recombinant human lactoferrin in the milk of transgenic goats.
Zhang J; Li L; Cai Y; Xu X; Chen J; Wu Y; Yu H; Yu G; Liu S; Zhang A; Chen J; Cheng G
Protein Expr Purif; 2008 Feb; 57(2):127-35. PubMed ID: 18054499
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of sheep lactoferrin, an inhibitor of platelet aggregation and comparison with human lactoferrin.
Qian ZY; Jollès P; Migliore-Samour D; Fiat AM
Biochim Biophys Acta; 1995 Jan; 1243(1):25-32. PubMed ID: 7827104
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.
van Berkel PH; van Veen HA; Geerts ME; de Boer HA; Nuijens JH
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):117-22. PubMed ID: 8870657
[TBL] [Abstract][Full Text] [Related]
29. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.
Hammerschmidt S; Bethe G; Remane PH; Chhatwal GS
Infect Immun; 1999 Apr; 67(4):1683-7. PubMed ID: 10085004
[TBL] [Abstract][Full Text] [Related]
30. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus.
El Yazidi-Belkoura I; Legrand D; Nuijens J; Slomianny MC; van Berkel P; Spik G
Biochim Biophys Acta; 2001 Dec; 1568(3):197-204. PubMed ID: 11786226
[TBL] [Abstract][Full Text] [Related]
31. Large scale production of recombinant human lactoferrin in the milk of transgenic cows.
van Berkel PH; Welling MM; Geerts M; van Veen HA; Ravensbergen B; Salaheddine M; Pauwels EK; Pieper F; Nuijens JH; Nibbering PH
Nat Biotechnol; 2002 May; 20(5):484-7. PubMed ID: 11981562
[TBL] [Abstract][Full Text] [Related]
32. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
[TBL] [Abstract][Full Text] [Related]
33. Role of basic residues of human lactoferrin in the interaction with B lymphocytes.
Kawasaki Y; Sato K; Shinmoto H; Dosako S
Biosci Biotechnol Biochem; 2000 Feb; 64(2):314-8. PubMed ID: 10737187
[TBL] [Abstract][Full Text] [Related]
34. Expression and characterization of recombinant human lactoferrin in edible alga Chlamydomonas reinhardtii.
Pang X; Tong Y; Xue W; Yang YF; Chen X; Liu J; Chen D
Biosci Biotechnol Biochem; 2019 May; 83(5):851-859. PubMed ID: 30669954
[TBL] [Abstract][Full Text] [Related]
35. "Dilysine trigger" in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin.
Peterson NA; Arcus VL; Anderson BF; Tweedie JW; Jameson GB; Baker EN
Biochemistry; 2002 Dec; 41(48):14167-75. PubMed ID: 12450380
[TBL] [Abstract][Full Text] [Related]
36. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
Hall A; Dalbøge H; Grubb A; Abrahamson M
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
[TBL] [Abstract][Full Text] [Related]
37. Ovine lactoferrin: isolation from colostrum and characterization.
Buchta R
J Dairy Res; 1991 May; 58(2):211-8. PubMed ID: 1856354
[TBL] [Abstract][Full Text] [Related]
38. Characterization of bovine and human lactoferrins as glycyrrhizin-binding proteins and their phosphorylation in vitro by casein kinase II.
Hatomi M; Tanigawa K; Fujihara M; Ito J; Yanahira S; Ohtsuki K
Biol Pharm Bull; 2000 Oct; 23(10):1167-72. PubMed ID: 11041245
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Proliferative Effect of Human Lactoferrin and Its Proteolytic Peptide on Normal and Transformed Epithelial Cells.
Hwang SM; Chung IY; Jo JH; Yoon TJ; Lee HH
Appl Biochem Biotechnol; 2016 Jan; 178(1):44-57. PubMed ID: 26400493
[TBL] [Abstract][Full Text] [Related]
40. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus.
Suzuki YA; Wong H; Ashida KY; Schryvers AB; Lönnerdal B
Biochemistry; 2008 Oct; 47(41):10915-20. PubMed ID: 18785755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
